Politician trade (House)

Johnson & Johnson (JNJ): Rep. Jared Moskowitz (FL23) disclosed a purchase $1K–$15K

Rep. Jared Moskowitz (FL23) disclosed a purchase of Johnson & Johnson in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount: 31 days
Disclosure lag

Traded: Nov 8, 2024
Disclosed: Dec 9, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Sep 10, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
Oct 29, 2024CongressDisclosed sale of JNJ — reported range $15,001 - $50,000
Nov 8, 2024 · this disclosureCongressDisclosed purchase of JNJ — reported range $1,001 - $15,000

What came next

Nov 22, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
Nov 25, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
Nov 26, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
Dec 6, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
Dec 10, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
Dec 12, 2024InsiderDirector purchased ~$147K of JNJ shares in the open market
Dec 12, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
Dec 24, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
Dec 31, 2024CongressDisclosed sale of JNJ — reported range $100,001 - $250,000
Jan 8, 2025Congress · 1 personMembers of Congress: 4 purchases
Jan 16, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
Jan 17, 2025FDAFDA drug approval: Spravato
Jan 17, 2025FDAFDA device clearance: TriALTIS Spine System
Jan 17, 2025FDAFDA device clearance: The ETHICON Total Energy System
Jan 21, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
Jan 22, 2025FDAFDA device clearance: EMPHASYS Acetabular System
Jan 23, 2025FDAFDA drug approval: Darzalex
Jan 23, 2025FDAFDA device clearance: MONARCH Platform (MON-000008)
Jan 24, 2025Congress · 2 peopleMembers of Congress: 1 purchase, 1 sale
Feb 5, 2025FDAFDA device clearance: GRYPHON X Anchor; HEALIX TRANSTEND Anchor

View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Johnson & Johnson

For Johnson & Johnson, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 119 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.

Other recent filings by Rep. Jared Moskowitz (FL23)

The full history of Rep. Jared Moskowitz (FL23) is on the profile page.

How this filing works

The STOCK Act

Explore the data

Other disclosures at Johnson & Johnson

Everything OQRO holds on this company is on its JNJ page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Start free trial Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data